Please join us on March 4, 2003 for a JETRO Executive Briefing,
"Biotechnology: The Kansai Midwest Relationship."

(See attached file: JETRO3.4.pdf)

The Japanese biotechnology market is forecast to reach $200 billion by 2010. As the Japanese biotech market continues to accelerate, the life science communities throughout the Midwest have an opportunity to discover business and research opportunities with their Japanese counterparts-opportunities perhaps never considered in the past, but critical to existing and aspiring global biotechnology companies and research institutes.

We are fortunate to have unprecedented access to three leading Biotechnology representatives from Japan’s Kansai area providing in-depth perspectives concerning Japan’s biotechnology market, licensing opportunities, investment in the commercialization of bio-innovation, and the incentives available for companies to do business in the Kansai area.

We welcome everyone in the Midwest life science and biotech communities to attend this very unique event. Following the presentations there will be an opportunity for questions and networking. Please evaluate our agenda and join us on March 4. There is no cost for this program, but please register in advance.

Date: March 4, 2003
Agenda: 9:30 am - 11:00 am, Registration begins at 9:15
Place: JETRO Chicago- Large Conference Room
401 N. Michigan Ave, Suite 660
Chicago, IL 60611

Register by fax, 312-832-6066, or online at
www.jetrocgo.org.

The Japan External Trade Organization (JETRO) was established in 1958 to promote mutually beneficial trade relations between Japan and countries around the world. As a non-profit, government affiliated organization, JETRO takes a leading role in initiating business and information partnerships with companies, organizations and universities. JETRO Chicago provides services to companies and organizations in 11 Midwest states.